| Old Articles: <Older 701-710 Newer> |
|---|
 |
Chemistry World
October 3, 2012
Bob Hefford |
Color and controversy The global market for oxidative hair colorants is huge and very profitable. But for 100 years, these products have been firmly based on just two chemicals: paraphenylenediamine and paratoluenediamine, both of which have a very checkered history.   |
Chemistry World
October 1, 2012
Bibiana Campos-Seijo |
Cosmetics, perfume and fashion We've decided to dedicate this issue to hair products, cosmetics, perfumes, fashion and the like. |
Chemistry World
September 19, 2012
Will Andrews |
The art of translation Chemistry improves the lives of millions of people via the beauty products they use every day. Translating cosmetic science may seem less relevant than, for example, biomedical research but it seeks to overcome the same issues. |
Chemistry World
September 6, 2012
Andrew Turley |
Valeant buys $2.6bn skincare firm Canadian pharma company Valeant is to buy US firm Medicis in a $2.6 billion deal. Medicis produces prescription dermatology products as well as over the counter products. |
Chemistry World
July 12, 2012 |
Drawing on drugs to kick the habit While pharma companies stand accused of giving up on drugs to help people stop smoking, tobacco firms are looking at controversial nicotine replacement products. Anthony King surveys an area that is problematic on all sides. |
Chemistry World
June 5, 2012 |
California chemical committee controversy Before governor Jerry Brown cut her from California's Developmental and Reproductive Toxicant Identification Committee, La Donna Porter had been heavily criticized for appearing in an ad opposing state efforts to fund health research through a tax on cigarettes. |
CFO
March 1, 2012
Sarah Johnson |
Avon Calling (For Help) A new CFO steps in as Avon attempts to step it up. |
The Motley Fool
January 20, 2012
Austin Smith |
Earnings Preview: What to Expect From Big Tobacco Make sure to stay tuned when these tobacco companies report earnings. |
The Motley Fool
January 17, 2012
Matt Koppenheffer |
What's Ahead for Procter & Gamble in 2012? Procter & Gamble is a dividend stalwart and an investor favorite. But what can investors expect next? |
The Motley Fool
January 17, 2012
Dan Caplinger |
What 2012 Has in Store for Star Scientific Let's look at this year's prospects for this company. |
| <Older 701-710 Newer> Return to current articles. |
